| MolName | 4-[5-[(Z)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide |
| MolecularFormula | C17H11N3O4S4 |
| Smiles | O=C(/C(/S1)=C/c2ccc(-c(cc3)ccc3S(Nc3nccs3)(=O)=O)o2)NC1=S |
| InChI | InChI=1S/C17H11N3O4S4/c21-15-14(27-17(25)19-15)9-11-3-6-13(24-11)10-1-4-12(5-2-10)28(22,23)20-16-18-7-8-26-16/h1-9H,(H,18,20)(H,19,21,25) |
| InChIK | FNZKESUWXSDPCX-UHFFFAOYSA-N |
| TotalMolweight | 449.555 |
| Molweight | 449.555 |
| MonoisotopicMass | 448.963237 |
| CLogP | 2.0075 |
| CLogS | -6.026 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 307.83 |
| Relative PSA | 0.50505 |
| PolarSurfaceArea | 195.31 |
| Druglikeness | 6.384 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | low |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.60714 |
| Fragments | 1 |
| Non HAtoms | 28 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| Rotatable Bond | 4 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 16 |
| Sp3Atoms | 3 |
| Symmetricatoms | 3 |
| Amides | 2 |
| Aromatic Nitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 4-[5-[(Z)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide | 2 - 4-[5-[(Z)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide